FOXD3 and central nervous system cancer: Although FOXD3-AS1 is significantly and positively correlated with the matrix score, immune score, and evaluation score in glioma, the standardized matrix score is secondary, indicating that samples with low immune invasion have high FOXD3-AS1 expression.